Isolation of a long-lasting eag-related gene-type K+ current in MMQ lactotrophs and its accommodating role during slow firing and prolactin release

J Neurosci. 2002 May 1;22(9):3414-25. doi: 10.1523/JNEUROSCI.22-09-03414.2002.

Abstract

Native rat lactotrophs express thyrotrophin-releasing hormone-dependent K+ currents consisting of fast and slow deactivating components that are both sensitive to the class III anti-arrhythmic drugs that block the eag-related gene (ERG) K+ current (I(ERG)). Here we describe in MMQ prolactin-releasing pituitary cells the isolation of the slowly deactivating long-lasting component (I(ERGS)), which, unlike the fast component (I(ERGF)), is insensitive to verapamil 2 microm but sensitive to a novel scorpion toxin (ErgTx-2) that hardly affects I(ERGF). The time constants of I(ERGS) activation, deactivation, and recovery from inactivation are more than one order of magnitude greater than in I(ERGF), and the voltage-dependent inactivation is left-shifted by approximately 25 mV. The very slow MMQ firing frequency (approximately 0.2 Hz) investigated in perforated patch is increased approximately four times by anti-arrhythmic agents, by ErgTx-2, and by the abrupt I(ERGS) deactivation. Prolactin secretion in the presence of anti-arrhythmics is three- to fourfold higher in comparison with controls. We provide evidence from I(ERGS) and I(ERGF) simulations in a firing model cell to indicate that only I(ERGS) has an accommodating role during the experimentally observed very slow firing. Thus, we suggest that I(ERGS) potently modulates both firing and prolactin release in lactotroph cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology
  • Animals
  • Anti-Arrhythmia Agents / pharmacology
  • Brain / metabolism
  • Calcium Channel Blockers / pharmacology
  • Cation Transport Proteins*
  • Cell Line
  • Computer Simulation
  • Dose-Response Relationship, Drug
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • Membrane Transport Proteins*
  • Models, Neurological
  • Patch-Clamp Techniques
  • Pituitary Gland / cytology
  • Pituitary Gland / drug effects
  • Pituitary Gland / physiology*
  • Potassium / metabolism*
  • Potassium Channels / drug effects
  • Potassium Channels / genetics
  • Potassium Channels / metabolism*
  • Potassium Channels, Voltage-Gated*
  • Prolactin / metabolism*
  • RNA / genetics
  • RNA / metabolism
  • Rats
  • Scorpion Venoms / isolation & purification
  • Scorpion Venoms / pharmacology
  • Tretinoin / metabolism
  • Verapamil / pharmacology

Substances

  • Anti-Arrhythmia Agents
  • Calcium Channel Blockers
  • Cation Transport Proteins
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • KCNH2 protein, human
  • KCNH6 protein, human
  • KCNH7 protein, human
  • Kcnh6 protein, rat
  • Kcnh7 protein, rat
  • Membrane Transport Proteins
  • Potassium Channels
  • Potassium Channels, Voltage-Gated
  • Scorpion Venoms
  • Tretinoin
  • RNA
  • Prolactin
  • Verapamil
  • Potassium

Grants and funding